Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Radiat Isot ; 202: 111064, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37866227

ABSTRACT

An extrapolation chamber of type Böhm 23392, used for the dosimetry of RQR beam qualities at the Secondary Standard Dosimetry Laboratory of King Faisal Specialist Hospital, is presented. A computer-based motorized system consisting of a stepping motor coupled to the chamber's built-in micrometer screw was designed to expedite the measurements process, giving a linear relationship between the number of motor steps and the chamber depth with a Coefficient of Determination (COD) equal to 0.9990. The extrapolation chamber along with the motorized system was used to determine the extrapolation curves. The slope of the extrapolation curves, measured for the eight RQR beam qualities with a relative uncertainty between 0.17% and 0.58%, varies linearly with the beam quality expressed in terms of HVL, with a COD between 0.9995 and 1.0000.

2.
Transplant Proc ; 47(3): 823-6, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25891740

ABSTRACT

We report a case of idiopathic membranoproliferative glomerulonephritis (MPGN) recurring 2 years after a living-unrelated kidney transplantation. The disease was refractory to intravenous immunoglobulin and plasmapheresis. Treatment with 2 doses of rituximab resulted in remission of the disease. The disease relapsed 18 months later after an episode of cytomegalovirus pneumonitis. After treatment of the pneumonitis, a lung biopsy was performed owing to persistent chest symptoms, which revealed bronchiolitis obliterans with organizing pneumonia. Bone marrow examination and culture revealed presence of acid-fast bacilli, and culture grew Mycobacterium tuberculosis. A repeated course of rituximab was withheld because of infection with tuberculosis, the patient's chest symptoms, and rare reports of noninfectious lung disease after the use of rituximab. The patient continues to have proteinuria with impaired kidney function.


Subject(s)
Glomerulonephritis, Membranoproliferative/drug therapy , Immunologic Factors/therapeutic use , Rituximab/therapeutic use , Combined Modality Therapy , Creatinine/blood , Glomerulonephritis, Membranoproliferative/pathology , Glomerulonephritis, Membranoproliferative/surgery , Humans , Kidney/pathology , Kidney/physiopathology , Kidney Transplantation , Male , Methylprednisolone/administration & dosage , Middle Aged , Plasmapheresis , Proteinuria/pathology , Pulse Therapy, Drug , Recurrence , Transplantation, Homologous , Treatment Failure
SELECTION OF CITATIONS
SEARCH DETAIL
...